Daewon Pharmaceutical Launches Convenient Squeezable Motion Sickness Medication 'Chazaltaek'

Effective Relief from Motion Sickness with Dimenhydrinate and Pyridoxine Combination

Daewon Pharmaceutical announced on the 13th that it has launched a new anti-motion sickness medication in a squeezable form, called 'Chazaltaek' (hereafter 'Chazalta').

Chazalta contains dimenhydrinate, an antihistamine, and pyridoxine hydrochloride, a type of vitamin B6, which work to suppress the central vomiting pathway. This makes it effective in preventing and alleviating symptoms such as dizziness, vomiting, and headache caused by motion sickness.

In particular, leveraging Daewon Pharmaceutical's expertise in syrup formulations, Chazalta has been developed as a liquid pouch type that can be conveniently consumed without water. It is easy to carry and take not only in cars but also during long-distance travel by airplane, train, or ship.

Additionally, since it does not contain any coloring agents or caffeine, it is safe for children as well as consumers who are sensitive to caffeine. The subtle grape flavor also makes it easy to take without discomfort.

A representative from Daewon Pharmaceutical stated, "Chazalta will be a great option for consumers who experience discomfort from motion sickness during the upcoming summer vacation season and holidays, when long-distance travel is common. We hope this new product will become a travel essential that the whole family can use together."

Chazalta is an over-the-counter medication and can be purchased at nearby pharmacies without a prescription.

This content was produced with the assistance of AI translation services.